Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Schmidt

Showing results (511-520 of 631) with videos related to

Pageof 64
Sort By:
Nature Communications|July 18, 2023
Automatically annotated motion tracking identifies a distinct social behavioral profile following chronic social defeat stressJoeri Bordes, Lucas Miranda, Maya Reinhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 19, 2015
Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic PropertiesJakob Hartmann, Klaus V Wagner, Steffen Gaali, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2021
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across wavesMirko Manchia, Anouk W Gathier, Hale Yapici-Eser, et al.
Biological Psychiatry|June 20, 2016
Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive DysfunctionAndrés Uribe-Mariño, Nils C Gassen, Maximilian F Wiesbeck, et al.
The Lancet. Oncology|March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trialVicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.
Biological Psychiatry Global Open Science|January 19, 2026
Mineralocorticoid Receptor in Glutamatergic Neurons Modulates Anxiety Exclusively in Male Mice Via Regulation of the Actin-Bundling Factor Fam107aHuanqing Yang, Sowmya Narayan, Joeri Bordes, et al.
Neuropharmacology|August 16, 2011
The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stressJakob Hartmann, Klaus V Wagner, Claudia Liebl, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 4, 2006
Radon activity concentration--a Euromet and BIPM supplementary comparisonA Röttger, A Honig, V Schmidt, et al.
Immunity|December 19, 2019
Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate LyaseMario A Lauterbach, Jasmin E Hanke, Magdalini Serefidou, et al.
Basic Research in Cardiology|February 1, 2023
Toll-like receptor-3 contributes to the development of aortic valve stenosisSven Thomas Niepmann, Nicola Willemsen, Ann Sophie Boucher, et al.
Pageof 64

Showing results (511-520 of 631) with videos related to

Sort By:
Pageof 64
Nature Communications|July 18, 2023
Automatically annotated motion tracking identifies a distinct social behavioral profile following chronic social defeat stressJoeri Bordes, Lucas Miranda, Maya Reinhardt, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|June 19, 2015
Pharmacological Inhibition of the Psychiatric Risk Factor FKBP51 Has Anxiolytic PropertiesJakob Hartmann, Klaus V Wagner, Steffen Gaali, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|November 24, 2021
The impact of the prolonged COVID-19 pandemic on stress resilience and mental health: A critical review across wavesMirko Manchia, Anouk W Gathier, Hale Yapici-Eser, et al.
Biological Psychiatry|June 20, 2016
Prefrontal Cortex Corticotropin-Releasing Factor Receptor 1 Conveys Acute Stress-Induced Executive DysfunctionAndrés Uribe-Mariño, Nils C Gassen, Maximilian F Wiesbeck, et al.
The Lancet. Oncology|March 30, 2019
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trialVicky Makker, Drew Rasco, Nicholas J Vogelzang, et al.
Biological Psychiatry Global Open Science|January 19, 2026
Mineralocorticoid Receptor in Glutamatergic Neurons Modulates Anxiety Exclusively in Male Mice Via Regulation of the Actin-Bundling Factor Fam107aHuanqing Yang, Sowmya Narayan, Joeri Bordes, et al.
Neuropharmacology|August 16, 2011
The involvement of FK506-binding protein 51 (FKBP5) in the behavioral and neuroendocrine effects of chronic social defeat stressJakob Hartmann, Klaus V Wagner, Claudia Liebl, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 4, 2006
Radon activity concentration--a Euromet and BIPM supplementary comparisonA Röttger, A Honig, V Schmidt, et al.
Immunity|December 19, 2019
Toll-like Receptor Signaling Rewires Macrophage Metabolism and Promotes Histone Acetylation via ATP-Citrate LyaseMario A Lauterbach, Jasmin E Hanke, Magdalini Serefidou, et al.
Basic Research in Cardiology|February 1, 2023
Toll-like receptor-3 contributes to the development of aortic valve stenosisSven Thomas Niepmann, Nicola Willemsen, Ann Sophie Boucher, et al.
Pageof 64